REG - Dr. Martens PLC - Annual Financial Report

Dr MartensAnnouncement

Tue 09:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250617:nRSQ0657Na&default-theme=true

RNS Number : 0657N  Dr. Martens PLC  17 June 2025

Dr. Martens plc (the "Company")

2025 Annual Report and Notice of Annual General Meeting

Further to the announcement of its preliminary results for the financial
period ended 30 March 2025 and in accordance with UK Listing Rules 6.4.1R,
6.4.3R and 10.6.13R, the Company announces that the following documents have
been submitted in unedited full text to the National Storage Mechanism and
will be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism:

·      Annual Report and Accounts for the financial period ended 30
March 2025 (the "2025 Annual Report")

·      Notice of the 2025 Annual General Meeting (the "2025 Notice of
Meeting"), which will take place at 9.30am on Thursday 10 July 2025 at 1-11
Hawley Crescent, Camden, London, NW1 8NP

·      Proxy form for the 2025 Annual General Meeting

·      Rules of the Dr. Martens Long Term Incentive Plan

In compliance with rule 6.3.5R of the Disclosure Guidance and Transparency
Rules, the 2025 Annual Report and 2025 Notice of Meeting are also available in
unedited full text on the Company's website, www.drmartensplc.com.

For further information, please contact:

Paul Rolling, Head of Secretariat

+447584243562

Bethany Barnes, Director of Investor Relations

+447825187465

ENDS

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global
presence. "Docs" or "DMs" were originally produced for their durability for
workers, before being adopted by diverse youth subcultures and associated
musical movements. Today, Dr. Martens has transcended its roots while still
celebrating its proud history. It operates in over 60 countries and employs
over 3,650 people worldwide. Its operations are split across both
Direct-to-Consumer and wholesale channels, and in addition to its
world-renowned "1460" boot its product segments span shoes including the 1461
shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as
well as a growing line of bags and accessories. Further information can be
found at https://www.drmartensplc.com/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSGPUGWQUPAGQQ